The Management of Closed Surgical Incisions Resulting From Incisional Hernia Repair and/or Functional Panniculectomy Using the Prevena™ Customizable™ Dressing
1 other identifier
interventional
71
1 country
2
Brief Summary
The goal of this study is to evaluate the impact of Customizable in the management of extensive closed surgical incisions for Subjects undergoing abdominal surgery for incisional hernia repair and/or functional panniculectomy as compared to SOC dressing, and to significantly reduce the SSC rate experienced by Subjects receiving Customizable vs. SOC surgical incision dressing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2015
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2014
CompletedFirst Posted
Study publicly available on registry
November 26, 2014
CompletedStudy Start
First participant enrolled
May 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2017
CompletedResults Posted
Study results publicly available
December 12, 2018
CompletedOctober 16, 2024
October 1, 2024
2.3 years
November 24, 2014
July 11, 2018
October 14, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants With Surgical Site Complications
Surgical Site Complications: * Dehiscence * Surgical site infection (SSI)
Within 30 Days Post-Surgical Procedure
Study Arms (2)
Standard of Care
ACTIVE COMPARATORdry sterile dressing/gauze and steristrips
Customizable
EXPERIMENTALPrevena Customizable Dressing with ActiV.A.C. Therapy Unit
Interventions
Eligibility Criteria
You may qualify if:
- an adult 18 years old or older of either gender
- able to provide their own informed consent
- will undergo:
- a functional panniculectomy with a transverse or a fleur-de-lis incision
- AND/OR -
- an incisional hernia repair with a vertical incision at least 20 cm in length and at least 10 cm of undermining on each side of the incision
- BMI equal to or greater than 30
- has maintained a stable weight for at least 3 months as determined by the Investigator (applies to post weight loss patients only)
- pre-operatively assessed to undergo a procedure with a CDC Wound Classification of:
- Class I (Clean): An uninfected operative wound in which no inflammation is encountered and the respiratory, alimentary, genital or uninfected urinary tract is not entered
- OR -
- Class II (Clean Contaminated): An operative wound in which the respiratory, alimentary, genital or uninfected urinary tract are entered under controlled conditions and without unusual contamination
- willing and able to return for all scheduled study visits
- if a female of child-bearing potential, must test negative on a urine pregnancy test
- if a female of child-bearing potential, must be willing to utilize an acceptable method of birth control (i.e. oral contraceptives, condom with spermicide, diaphragm with spermicide, implants, IUD, injections, vaginal rings, hormonal skin patch) for the duration of the study
- +1 more criteria
You may not qualify if:
- has a systemic bacterial or fungal infection at the time of surgery for incisional hernia repair and/or functional panniculectomy
- has a remote-site skin infection at the time of surgery for incisional hernia repair or functional panniculectomy
- pre-operatively assessed to undergo a procedure with a CDC Wound Classification of:
- Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
- OR -
- Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera
- will have a transverse or fleur-de-lis incision that extends beyond the flank area and requires moving the Subject from the supine position during surgery
- has a known allergy or hypersensitivity to silver, or drape materials that contain acrylic adhesives
- has participated in a clinical study within the past 30 days
- who, in the investigator's opinion, would have any clinically significant condition that would impair the Subject's ability to comply with the study procedures
- determined to have a CDC Wound Classification of:
- Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
- OR -
- Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KCI USA, Inclead
Study Sites (2)
Medical Research Center
Miami, Florida, 33144, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
Limitations and Caveats
The study was terminated after an interim data review as the SSC rates were outside the ranges of the sample size assumptions used for the study design.
Results Point of Contact
- Title
- Sr Director, Global Clinical Development
- Organization
- Acelity
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- GT60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 24, 2014
First Posted
November 26, 2014
Study Start
May 1, 2015
Primary Completion
July 31, 2017
Study Completion
July 31, 2017
Last Updated
October 16, 2024
Results First Posted
December 12, 2018
Record last verified: 2024-10